Notably, HDAC6 inhibition activates DNA damage repair pathways by upregulating cellular stress genes such as DDIT4 (RTP801/Dig2/REDD1) and DDIT3 (CHOP/GADD153), highlighting its potential as a therapeutic target in cancer treatment [25]. The gene discussed is HDAC6; the disease is cancer.